Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection

Status unconfirmed · Phase 4 · Has a placebo group

Conditions studied: Clostridium Difficile Infection

In brief

We are doing this research study to determine if taking vancomycin in addition to a broad-spectrum antibiotic will decrease the chance of developing recurrent Clostridium difficile infection.

Key facts

Study ID

NCT02237859

Run by

Corewell Health West

People needed

140

Starts

2014-08-01

Expected to finish

2016-08-01

Last updated by the study team

2014-09-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• In patients >19 years of age
• History of C. difficile diarrhea within 16 weeks and treated with Flagyl or Vancomycin during last episode.
• Patients started on antibiotics during current admission for any other indication at any point of time during hospital course.

You may not qualify if…

• Current diagnosis of CDI
• First episode of CDI during this admission.
• Allergy to Vancomycin or other known intolerance
• Pregnant
• h) Patient has received broad-spectrum antibiotics for more than 48 hours for this admission j) Incarceration

Where it is running

• Spectrum Health Hospital — Grand Rapids, Michigan, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.